| Followers | 245 |
| Posts | 13889 |
| Boards Moderated | 0 |
| Alias Born | 05/19/2015 |
Friday, July 01, 2022 7:04:33 AM
LoL! That’s like saying don’t answer because we don’t want anyone to know the truth or facts! There is much reason for truthful answer and facts, funny how non-scientist or those without a degree or PHD can say a highly educated scientist or MD with a PHD is not qualified to write a white paper. LoL!
dCellVax Breast Cancer – dCellVax – IND #16200. CellVax is a dendritic cell based immunotherapy that stimulates the patient’s immune system through a process called “gene silencing.” Establishment of safety will allow for rapid expansion of patient numbers. Currently addressing FDA questions with Dr. Santosh Kesari, head of UCSD Neuro-Oncology program.
RGBP’s MD, PHD Dr. Brian not only Oxford educated but
Also Harvard Medical school!
https://www.brighamandwomens.org/about-bwh/bwh-history
Misinformation is just that misinformation!
Scientists Dr. Brian KOO’s has all the credentials to write the RGBP white paper publication he is Harvard and Oxford educated PHD and MD
he has wrote 52 publications.
https://twitter.com/XTREM1_JUNIOR6/status/1517880534566785024/photo/1
LoL! For those that want the truth!
Not only RGBP’s team in the filings some are beneficial owners!
dCellVax Breast Cancer – dCellVax – IND #16200. CellVax is a dendritic cell based immunotherapy that stimulates the patient’s immune system through a process called “gene silencing.” Establishment of safety will allow for rapid expansion of patient numbers. Currently addressing FDA questions with Dr. Santosh Kesari, head of UCSD Neuro-Oncology program.
RGBP’s MD, PHD Dr. Brian not only Oxford educated but
Also Harvard Medical school!
https://www.brighamandwomens.org/about-bwh/bwh-history
Misinformation is just that misinformation!
Scientists Dr. Brian KOO’s has all the credentials to write the RGBP white paper publication he is Harvard and Oxford educated PHD and MD
he has wrote 52 publications.
https://twitter.com/XTREM1_JUNIOR6/status/1517880534566785024/photo/1
LoL! For those that want the truth!
Not only RGBP’s team in the filings some are beneficial owners!
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
